Board of Directors

Eurobio Scientific Team

Denis Fortier

Chief Executive Officer

Denis Fortier

Denis Fortier is Chairman and CEO of Eurobio Scientific since June 2023. He is particularly in charge of R&D, production, export and business development. He was previously a member of Eurobio Scientific's Management Board since 2017, Director of Eurobio Scientific, and General Manager of the Group since 2019.

Denis Fortier has more than 30 years of experience in in vitro diagnostics and the biotechnology industry, and has dual experience as a leader and entrepreneur. With a Master's degree in Biotechnology and Business, he began his career by holding various marketing and commercial positions in diagnostics companies. He became International Director and then Head of Business Development at diagnostics company BMD (now Theradiag). He then joined the General Management of Inodiag, a start-up in the field of diagnostics for infectious diseases, where he was in charge of development and financing.

In 2010, he acquired with Jean-Michel Carle Grandmougin the Eurobio laboratories which he joined as General Manager to oversee production, R&D, business development and export. He is a member of the Entreprendre network, to help start businesses and follow up young entrepreneurs.

Denis Fortier owns approximately 34% of the EurobioNext holding company which holds approximately 30% of Eurobio Scientific's capital.

Biography

Jean-Michel Carle Grandmougin

Business developer Group Director

Jean-Michel Carle Grandmougin

Jean-Michel Carle Grandmougin is a Director of EUROBIO SCIENTIFIC and Deputy General Manager since June 2023. He is in charge of the group's marketing and sales as well as sales in France. He was previously President of EUROBIO SCIENTIFIC's Management Board since 2017, and Chairman and CEO since 2019. He is also President of the EUROBIONEXT holding company which is EUROBIO SCIENTIFIC's reference shareholder.

Jean-Michel Carle Grandmougin has more than 35 years of experience in the field of in vitro diagnostics and research in life sciences. Before becoming a member of the Management Board of the DIAXONHIT Group, he was Chairman and Chief Executive Officer and one of the two partners of the EUROBIO / Capforce Group which was acquired by DIAXONHIT in March 2017. He joined EUROBIO SA in 2006 as Sales Manager and quickly became its Managing Director.

In June 2010, he acquired the company with Denis Fortier and the OTC Asset Management fund which sold back its shares in 2014 to Jean-Michel and Denis. In 1992, he joined BMD (now Theradiag) where he was Sales Director for 13 years before taking responsibility of its German activity. Holder of a bachelor's degree in biology, he began his career in 1985 at Technicon (now Bayer Diagnostics) as a Technical Sales Engineer to become Sales Manager at 30.

Jean-Michel Carle Grandmougin owns approximately 27% of the EUROBIONEXT holding company which holds approximately 30% of EUROBIO SCIENTIFIC's capital.

Biography

Catherine Courboillet

Administrator

Catherine Courboillet

Catherine Courboillet has over 30 years of experience in the life sciences and medical diagnostics fields. She started her career at Pharmacia DIAG, a Swedish in vitro diagnostic company, where she quickly took on several leadership roles, including in sales and marketing. She then developed the specialized biology laboratory at Générale de Santé (Ramsay Santé) before joining Laboratoire Cerba in 1999 as Deputy CEO, later becoming President in 2005. Thanks to her strategic vision and commitment to innovation and prevention for all patients, Catherine Courboillet led the development of the Cerba HealthCare group for 23 years, turning it into a key player in the medical diagnostics market in France and Europe. The group's growth was driven by a strong medical project focused on quality diagnostics and operational excellence, external growth in France and internationally, innovation and digitalization in patient journeys, and consideration of societal and environmental issues.

Catherine Courboillet will assume the role of Chair of the Supervisory Board of the Point Vision group in July 2024, alongside Stanislas Guedj, President of the Point Vision group.

Biography

Hervé Duchesne de Lamotte

Administrator

Hervé Duchesne de Lamotte

Hervé Duchesne de Lamotte is a Director of EUROBIO SCIENTIFIC. He was a member of the prior Management Board since 2010. He was General Manager of the Group since 2019 where he was in charge of M&A activities.

Hervé Duchesne de Lamotte has over 35 years of international financial experience, including 30 years within the biotechnology and diagnostics industries. After having held a variety of project management positions in consultancy firms in France and the United States between 1981 and 1989, Hervé Duchesne de Lamotte took up a senior position at Paris-based asset management firms. In 1991, he moved into pharma and biotechnology as a co-founder of the IDM group, a biotechnology company where he served from 1998 as CFO for 10 years in France, Canada, and the United States. From 2006 to 2008 he was subsequently appointed General Manager France, at IDM Paris until selling the company to the Takeda pharmaceutical group in 2009. Prior to joining Eurobio Scientific, Hervé Duchesne de Lamotte managed Cirrus Finance Management, a consultancy firm specializing in business and organizational strategies. He served as Board member of IDM and France Biotech.

Hervé Duchesne de Lamotte has an MBA in finance and a Master of Science from MIT. His first degree was in aeronautical engineering (SupAero).
‍

Biography

Gregoire Sentilhes

Administrator-EurobioNext Representative

Gregoire Sentilhes

Gregoire Sentilhes was the CEO of Screaming Media, a value-added content syndication company that was listed on NASDAQ in 2000 and recently merged with CBS Market Watch. He was previously based in New York as Vice President of Global Marketing for the e-commerce division of the German Bertelsmann Group. He was previously co-founder and CEO of the Lagardère Group's online division in Paris from 1993 to 1996. He has successfully invested in unlisted companies in France, Spain, the United States and China: 4 of his 15 investments have been listed on the stock exchange. An alumnus of ISG, he studied at the University of Paris Dauphine. He was a member of the France III sailing team, the French challenger for the America's Cup. He is a member of the board of France Investissement, and co-founder of the Journées de l'Entrepreneur. In 2010, he became the President of the G20 Young Entrepreneurs (G20 YES).

The EUROBIONEXT holding company, which he represents, holds approximately 30% of EUROBIO SCIENTIFIC's capital.

Biography

Michel Picot

Administrator

Michel Picot

Michel Picot began his career as an auditor at Peat Marwick Mitchell before moving to the SCOA, a Parisbas affiliate. He moved to ECS Germany before joining Eunetcom as Senior Vice President of Finance. He was Deputy Chief Executive Officer at Vivendi Telecom International for almost 10 years. He has been President of Advest SAS since 2005. He has also been Chairman of the Supervisory Board of Elektrion Telekomunikaeja since 2001 and he has been a Director of Keyyo since 2005.

Michel is a graduate of HEC (Hautes Etudes Commerciales) and has several degrees in accounting and control (DECS).

Biography

Patrick de Roquemaurel

Administrator

Patrick de Roquemaurel

Patrick de Roquemaurel cumulates more than 30 years of experience in Industry and Finance, particularly in Information Technology. He has held various sales management positions at Tandem Computer and Stratus Computers. He was General Manager of Business Unit at Siemens Nixdorf France and Vice President of Bull's service activities. In 2007, he joined OTC Asset Management as Director of Investments. As such, he invested in the technology and healthcare sectors, including the acquisition of Eurobio jointly with its management in 2010. In early 2016, he left OTC Asset Management and joined the Extendam management company in July 2016 as General Manager.

Patrick de Roquemaurel is a graduate of ESLSCA, Paris (1978).

Biography